Leukaemias into the 21st century. Part 2: the chronic leukaemias

Area of Science:

• Hematology
• Oncology
• Molecular Genetics

Background:

• Chronic leukaemias are categorized based on their cell lineage, similar to acute leukaemias.
• Chronic myeloid leukaemia (CML) and chronic lymphocytic leukaemia (CLL) are the predominant types within myeloid and lymphoid lineages, respectively.
• Several less common chronic leukaemia subtypes are also recognized.

Purpose of the Study:

• To summarize the classification and recent advancements in chronic leukaemias.
• To highlight the progress in understanding the biology and molecular genetics of these diseases.
• To underscore the translation of biological insights into therapeutic progress.

Main Methods:

• Literature review and synthesis of current knowledge on chronic leukaemias.
• Analysis of classification systems based on cell lineage.
• Examination of recent research in molecular genetics and therapeutic development.

Main Results:

• Chronic leukaemias are classified into myeloid and lymphoid groups, with CML and CLL as primary examples.
• Significant progress has been made in understanding the underlying biology and molecular aberrations.
• These advancements are directly contributing to the development of novel and effective treatments.

Conclusions:

• The classification of chronic leukaemias remains crucial for diagnosis and understanding.
• Continued research into the molecular basis of chronic leukaemias is essential for future therapeutic innovations.
• The field is rapidly evolving, offering improved outcomes for patients with chronic leukaemias.